in 2016. Kuramax Medikal LLC, which imported the company's products to Uzbekistan, was registered in Uzbekistan in 2006, headed by Singh Ragvendra Pratar. The Narcotics Licensing and Control Authority of Uttar Pradesh has been entrusted with the investigation. On December 29, 2022, Marion Biotech officially stopped the production of its Dok-1 Max cough syrup, which had caused the death of more than 20 children in Uzbekistan. According to the Economic Times, the investigative commission asked the government of Uzbekistan for a report on children who died as a result of drug. In connection with this incident, the Investigation Department of the State Security Service of Uzbekistan initiated a criminal case against the officials of Kuramax Medikal and Scientific Center for Standardization of Medicines under Article 186-3, Part 4, Clause "a" of the Criminal Code. Suspects were arrested. Among the 7 officials released from their positions is Mamatqul Azizov, who discovered that the syrup was dangerous and that it was this drug that caused the death of children. News began to spread that these officials may be reinstated. Kun.uz website reports that the newly appointed Minister of Health Amrillo Inoyatov held a meeting with 7 dismissed officials. The Dok-1 Max drug exported from India to Uzbekistan was subjected to laboratory tests by Scientific Center for Standardization of Medicines LLC. However, the review was not systematic, meaning that the drugs were not thoroughly tested. State security authorities arrested two heads of Kuramax Medikal LLC and Scientific Center for Standardization of Medicines as suspects in connection with this case. On the night of December 30, 2022, a special task force formed by the Indian government with the participation of the Drug Standards Control Center and the Uttar Pradesh Drug Control Department completed the inspection of the Marion Biotech pharmaceutical factory. As a result of the investigation, government officials demanded the end of production, and the company's manufacturing plants in Noida, as well as the production of Nolgripp, Sinepar, Dok-1 Max, Travamax and other similar drugs, were suspended. On January 2, 2023, the sale of all drugs imported by Kuramax Medikal that were found to contain ethylene glycol and diethylene glycol was stopped. On January 10, the Indian government suspended the license of Marion Biotech, the manufacturer of Dok-1 Max. On January 13, the license of Kuramax Medikal LLC was revoked by a decision of the Tashkent Interdistrict Economic Court. See also Toxic cough